タキザワ マキコ
TAKIZAWA Makiko
滝沢 牧子 所属 埼玉医科大学 医学部 総合医療センター 医療安全管理学 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7 |
掲載誌名 | 正式名:Genes to Cells ISSNコード:1356-9597 |
巻・号・頁 | 6(12),1091-1099頁 |
著者・共著者 | Makoto Yanagisawa,Kinichi Nakashima,Kohsuke Takeda,Wataru Ochiai,Takumi Takizawa,Masaya Ueno,Makiko Takizawa,Hiroshi Shibuya,Tetsuya Taga |
発行年月 | 2001 |
概要 | Background: BMP2 is known to play a wide variety of roles, including some in the development of the nervous system. This cytokine has been reported to induce neurite outgrowth in rat pheochromocytoma PC12 cells via the activation of a p38 MAP kinase, although its regulatory mechanism remains largely to be elucidated. Results: BMP2-induced neurite outgrowth in PC12 cells was inhibited by the introduction of a kinase-negative form of a MAP kinase kinase kinase, TAK1, an upstream regulatory kinase for p38 kinase. Following BMP2 stimulation, the expression of Smad6 and Smad7, inhibitory Smad species that are known to inhibit the BMP2-restricted Smad species, Smad1, Smad5 and Smad8, was up-regulated. Unexpectedly, over-expression of either Smad6 or Smad7 in PC12 cells repressed the BMP2-induced neurite outgrowth and severely impeded the p38 kinase pathway. Both of these inhibitory Smads were found to interact physically with TAK1-binding protein, a molecule required for TAK1 activation. Conclusions: This study demonstrates that BMP2-induced neurite outgrowth in PC12 cells involves activation of the TAK1-p38 kinase pathway which is inhibited by Smad6 and Smad7. |
DOI | 10.1046/j.1365-2443.2001.00483.x |
PMID | 11737269 |